Clinical trials: Newly Diagnosed Breast Cancer
Cancer
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing.
- Trial name
- NCT00499733
- Testing
- cyclophosphamide, Cryoablation
- Where
- United States
- Volunteers
- 19 people
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Breast Cancer
Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer
RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop tumor cells from dividing so they stop growing or die.
- Trial name
- NCT00080626
- Testing
- pegfilgrastim, docetaxel, conventional surgery
- Where
- United States
- Volunteers
- 19 people
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
HER2-positive Breast Cancer
Fasting on Newly Diagnosed Breast Cancer
This study is to see how safe the use of short-term fasting is in breast cancer patients who will receive chemotherapy before undergoing surgery and to examine if the use of short-term fasting will decrease the side effects of…
- Trial name
- STEFNE (NCT02379585)
- Testing
- Doxorubicin, cyclophosphamide, paclitaxel
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- Western Regional Medical Center
Breast Cancer, Cognitive/Functional Effects
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
RATIONALE: Learning about changes over time in older patients' ability to function after receiving chemotherapy for breast or colon cancer may help doctors learn about the long-term effects of treatment and plan the best…
- Conditions
- Breast Cancer, Cognitive/Functional Effects, Colorectal Cancer, Psychosocial Effects of Cancer and Its Treatment
- Trial name
- NCT00740961
- Testing
- compliance monitoring, systemic chemotherapy, medical chart review
- Where
- 5 sites in United States
- Volunteers
- 63 people
- Sponsor
- Case Comprehensive Cancer Center
Newly Diagnosed Breast Cancer
Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer
This is a single institution study enrolling women over age 25 with newly diagnosed breast cancer and for whom a breast MR has been ordered as standard of care.
- Trial name
- NCT03510988
- Testing
- Hybrid breast FDG PET/MRI
- Where
- United States
- Volunteers
- 14 people
- Sponsor
- Weill Medical College of Cornell University